An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics
- PMID: 1462981
- DOI: 10.1016/s0272-6386(12)70217-2
An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics
Abstract
Clinical diabetic nephropathy in man is the consequence of the development of a specific constellation of glomerular, tubular, vascular, and interstitial structural abnormalities accompanied by highly characteristic immunohistochemical alterations that, together, are unique to diabetes. Because changes resembling the specific pathology of diabetes do not develop in patients with conditions that lead to long-standing glomerular hyperfunction (such as unilateral nephrectomy), it is unlikely that glomerular hemodynamic abnormalities per se can be the cause of diabetic nephropathy. Whether hemodynamic abnormalities represent a risk factor that, in the presence of the diabetic state, can accelerate the rate of development of the basic lesions of diabetic nephropathy is currently unclear. However, there is considerable evidence that when the renal lesions of diabetes are far advanced, factors such as systemic hypertension can determine the rate of renal functional deterioration in diabetes as in other disorders. Although the diabetic rat may be a useful model for the study of aspects of the pathogenesis of diabetic nephropathy, much confusion has resulted from the inclusion of focal segmental glomerular sclerosis as a diabetic lesion. Similarly, the acceptance of all increases in urinary protein excretions in this model as resulting from or reflecting of diabetic nephropathology can be misleading. It is concluded that treatment aimed at manipulating renal hemodynamics in diabetic patients without evidence of renal disease should remain in the realm of clinical research.
Similar articles
-
Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.FASEB J. 1988 May;2(8):2339-47. doi: 10.1096/fasebj.2.8.3282959. FASEB J. 1988. PMID: 3282959 Review.
-
Diabetic nephropathy. A perspective.Diabetes. 1983 May;32 Suppl 2:52-5. doi: 10.2337/diab.32.2.s52. Diabetes. 1983. PMID: 6400668 Review.
-
Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:1-7. doi: 10.1055/s-0029-1211783. Exp Clin Endocrinol Diabetes. 1997. PMID: 9288531 Review.
-
Structural involvement in type 1 and type 2 diabetic nephropathy.Diabetes Metab. 2000 Jul;26 Suppl 4:8-14. Diabetes Metab. 2000. PMID: 10922968 Review.
-
Renal structure and function in insulin-dependent diabetes mellitus and type I membranoproliferative glomerulonephritis in humans.J Am Soc Nephrol. 1992 Apr;2(10 Suppl):S181-4. doi: 10.1681/ASN.V210s181. J Am Soc Nephrol. 1992. PMID: 1600134 Review.
Cited by
-
Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation.Physiol Rep. 2014 Nov 26;2(11):e12208. doi: 10.14814/phy2.12208. Print 2014 Nov 1. Physiol Rep. 2014. PMID: 25428948 Free PMC article.
-
Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy.Exp Mol Med. 2017 Mar 31;49(3):e310. doi: 10.1038/emm.2016.169. Exp Mol Med. 2017. PMID: 28360429 Free PMC article.
-
Diabetic nephropathy.BMJ Clin Evid. 2009 Jan 14;2009:0606. BMJ Clin Evid. 2009. PMID: 19445773 Free PMC article.
-
Diabetic nephropathy: preventing progression.BMJ Clin Evid. 2010 Jul 8;2010:0606. BMJ Clin Evid. 2010. PMID: 21418671 Free PMC article.
-
Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.PLoS One. 2013;8(1):e54863. doi: 10.1371/journal.pone.0054863. Epub 2013 Jan 22. PLoS One. 2013. PMID: 23349979 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical